Racial Differences in 21-Gene Recurrence Scores Among Patients With Hormone Receptor-Positive, Node-Negative Breast Cancer.

Conclusion NHBs who met clinical criteria for 21-gene RS testing had tumors with higher estimated risks of distant recurrence compared with NHWs. Further study is needed to elucidate whether differences in recurrence are observed for these women, which would have clinical implications for 21-gene RS calibration and treatment recommendations in NHB patients. PMID: 29341832 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/29341832?dopt=Abstract

Source: Clinical Breast Cancer - January 17, 2018 Category: Cancer & Oncology Authors: Holowatyj AN, Cote ML, Ruterbusch JJ, Ghanem K, Schwartz AG, Vigneau FD, Gorski DH, Purrington KS Tags: J Clin Oncol Source Type: research